FNDC4 (rec.) (untagged)
AG-40B-0124-C01010 µgCHF 270.00
AG-40B-0124-C05050 µgCHF 850.00
|Synonyms||Fibronectin Type III Domain-containing Protein 4; Fibronectin Type III Repeat-containing Protein 1|
|Sequence||FNDC4 (extracellular domain, human (aa 45-167) / mouse (aa 41-163)) is untagged. FNDC4 extracellular domain has 100% identity between human, mouse, rat, dog and monkey.|
|Endotoxin Content||<0.01EU/μg purified protein (LAL test; Lonza).|
for 10µg size: 0.1mg/ml
for 50µg size: 1 mg/ml
10µg size: Reconstitute with 100µl sterile water.
50µg size: Reconstitute with 50µl sterile water.
|Formulation||Lyophilized. Contains PBS.|
|Other Product Data||Uni-Prot link Q9H6D8: FNDC4|
|Shipping and Handling|
|Short Term Storage||+4°C|
|Long Term Storage||-20°C|
After reconstitution, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
PBS containing at least 0.1% BSA should be used for further dilutions.
|Use/Stability||Stable for at least 6 months after receipt when stored at -20°C.|
|Product Specification Sheet|
Irisin is a recently described exercise-induced hormone secreted by skeletal muscle in mice and humans. Irisin activates beige fat cells (beige cells have a gene expression pattern distinct from either white or brown fat and are preferentially sensitive to the polypeptide hormone irisin). Irisin is cleaved from the type I membrane protein FNDC5 and improves systemic metabolism by increasing energy expenditure. FNDC4 is an ortholog of FNDC5 with 50% identity and 86% similarity compared to Irisin. FNDC4 as well as FNDC5 are extremely well conserved between species. The human FNDC4 gene is highly enriched in liver, brain tissue and adipocytes. FNDC4 is a factor with direct therapeutic potential in inflammatory bowel disease and possibly other inflammatory diseases.